Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Randomized, Controlled Multicenter Clinical Study to Evaluate the Safety and Effectiveness of the Spiration® Valve System for the Single Lobe Treatment of Severe Emphysema

NCT01812447 is registered in ClinicalTrials.gov with Olympus Corporation of the Americas as lead sponsor.

NCT NCT01812447
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01812447 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Randomized, Controlled Multicenter Clinical Study to Evaluate the Safety and Effectiveness of the Spiration® Valve System for the Single Lobe Treatment of Severe Emphysema
Lead sponsor
Olympus Corporation of the Americas
Phase
Not applicable
Overall status
Completed
Start date
June 30, 2013
Completion date
August 31, 2022
Enrollment
172 (actual)
Sites
34

Conditions

As the registry lists them; a condition with its own page is linked.

emphysema